IFNA1 and systemic lupus erythematosus: EGA may therefore serve as another potent immune modulator and might also have potential efficacy in controlling cytokine responses of pDCs in SLE, as we demonstrated that EGA can diminish IFNα expression by pDCs stimulated with TLR7 and TLR9 (27) ligands.